U.S. Healthcare Services Stock News

Earnings results and 2026 outlook draw fresh focus to GDS Holdings GDS Holdings (GDS) is back in the spotlight after reporting fourth quarter and full year 2025 results that combined higher revenue with sharply weaker profitability, along with 2026 revenue guidance pointing to further top line expansion. See our latest analysis for GDS Holdings. The share price reaction to the latest earnings and 2026 guidance has been negative in the short term, with a 1 day share price return of a 6.69%...

Wondering if Arcellx at around US$114 per share still offers value, or if the easy money has already been made. The stock has YTD returns of 81.0% and a 1 year return of 68.7%, although the past week has been flat at around a 0.1% decline and the 30 day move sits at 0.8%. Recent coverage has focused on Arcellx as a higher growth biotech name, which helps explain why the share price has been so strong over the past year. That kind of attention often shifts how investors think about both the...

Why Carlyle Group Stock Is On Investors’ Radar Carlyle Group (CG) has drawn fresh attention after a period of weaker share performance, with the stock declining about 8% over the past month and roughly 23% over the past 3 months. At a last close of US$46.77, the firm carries a market value of about US$16.98b, supported by reported revenue of US$4,031.6m and net income of US$808.7m across its global investment platform. See our latest analysis for Carlyle Group. The recent 1 month share price...

Arlo Technologies recently reported a past quarter in which revenue grew 16.2% year on year, beating analyst forecasts by 4.2% and delivering earnings per share above expectations for both the reported period and its next-quarter guidance. The company also moved from negative to positive full-year earnings per share over the last five years, highlighting a key profitability inflection that builds on its 8.2% annualized revenue growth in the same period. Next, we will examine how Arlo’s...

Intellicheck, Inc. ( NASDAQ:IDN ) recently posted some strong earnings, and the market responded positively. We did...

Why 10x Genomics Is Back in Focus 10x Genomics (TXG) is back on investor watchlists after two catalysts: its role in Bioptimus’ new STELA spatial tissue atlas, and steady share purchases by high profile fund manager Cathie Wood. See our latest analysis for 10x Genomics. The recent partnership on the STELA initiative and continued buying from Cathie Wood have arrived while the share price sits at US$20.43, with a 90 day share price return of 23.89% and a 1 year total shareholder return of...

Over the last 7 days, the United States market has experienced a 1.6% decline, though it remains up by 15% over the past year with earnings projected to grow by 16% annually. In this context, identifying small-cap stocks that are potentially undervalued and exhibit insider action can offer intriguing opportunities for investors seeking to navigate these dynamic market conditions.

Over the last 7 days, the United States market has experienced a 1.6% drop, yet it has shown resilience with a 15% increase over the past year and expectations for earnings to grow by 16% annually in the coming years. In this context of fluctuating short-term performance but promising long-term growth prospects, identifying high growth tech stocks that can capitalize on these trends becomes essential for investors seeking potential opportunities.

Wondering whether PROG Holdings at around US$29.02 actually offers value, or if the recent share price leaves limited upside? This breakdown helps you frame that question with numbers, not guesswork. The stock is up 3.8% over the last week, sits at a 21.7% decline over 30 days, and is around 1.2% lower year to date. The 1 year and 3 year returns are 7.7% and 33.6%, and the 5 year return is a 33.8% decline. Recent headlines around PROG Holdings have focused on its position within the broader...

Over the last 7 days, the United States market has experienced a 1.6% decline, yet it has shown resilience with a 15% rise over the past year and an anticipated earnings growth of 16% annually in the coming years. In this environment, identifying stocks that may be underestimated requires looking beyond short-term fluctuations to find companies with strong fundamentals and potential for long-term value appreciation.

Wondering if Apollo Global Management at around US$109.98 is offering good value, or if the market is asking too much for the stock right now. The share price has seen a 1.2% decline over the last week and 3.6% over the past month, set against a 25.0% decline year to date and a 21.4% decline over the last year. The 3 year and 5 year returns sit at 88.1% and 154.6% respectively. Recent headlines around Apollo Global Management have focused on its role as a major diversified financial player...

Over the last 7 days, the United States market has experienced a 1.6% drop, yet it remains up by 15% over the past year with earnings projected to grow by 16% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they often signal confidence from those closest to the business and may offer potential opportunities for investors seeking alignment of interests.

SouthState Bank (NYSE:SSB) announces a new share repurchase plan approved by its board. The company pairs the buyback authorization with CEO comments pointing to strong business performance. An analyst upgrade follows, signaling increased confidence in SouthState Bank's outlook. SouthState Bank, a regional banking franchise listed on the NYSE under the ticker SSB, operates in a sector that has been closely watched for capital returns, credit quality and funding costs. A fresh share...

Over the last 7 days, the market has dropped 1.6%, but it remains up by 15% over the past year, with earnings expected to grow by 16% annually. In such a climate, identifying stocks with solid financial health can be crucial for investors looking for growth opportunities. Penny stocks—often associated with smaller or newer companies—still hold potential when they demonstrate financial strength and long-term promise.

Why Oceaneering International (OII) Is On Investors’ Radar Today Recent performance in Oceaneering International (OII) has caught investor attention, with the stock showing a mix of strong past 3 months and 1 year total returns alongside a weaker month. Against that backdrop, the company’s US$2.8b in revenue and US$353.8m in net income, spread across offshore energy and defense related segments, provide a broad based business to assess beyond short term share price moves. See our latest...

Over the last 7 days, the United States market has experienced a slight dip of 1.6%, yet it remains robust with a 15% increase over the past year and anticipated earnings growth of 16% per annum in the coming years. In this dynamic environment, identifying stocks that are undervalued or overlooked can provide unique opportunities for investors seeking to capitalize on emerging potential within a thriving market.

Over the last 7 days, the United States market has experienced a 1.6% drop, yet it has seen a notable increase of 15% over the past year, with earnings expected to grow by 16% annually. In this dynamic environment, selecting dividend stocks that offer both stability and growth potential can be an effective strategy for investors seeking reliable income streams and long-term value.

One thing we could say about the covering analyst on Perma-Fix Environmental Services, Inc. ( NASDAQ:PESI ) - they...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Readers hoping to buy Zimmer Biomet Holdings, Inc. ( NYSE:ZBH ) for its dividend will need to make their move shortly...

Even if it's not a huge purchase, we think it was good to see that Edward Stenger, the Independent Director of Team...

LENZ Therapeutics, Inc. ( NASDAQ:LENZ ) just released its latest yearly report and things are not looking great. It was...

The Morning Bull - US Market Morning Update Friday, Mar, 27 2026 US stock futures are mixed this morning, with S&P 500 contracts hovering near flat as investors weigh higher borrowing costs against hotter inflation and geopolitical risk. The US 10 year Treasury yield is holding around 4.41%, which keeps pressure on everything from credit cards to business loans, while the average 30 year mortgage rate sits at 6.38%, keeping home buying more expensive. At the same time, Middle East tensions...

This article examines whether Raymond James Financial at around US$144.20 is offering good value or is priced too high, and walks through what the current price might imply. The stock is up 0.9% over the last 7 days, while the 30 day and year to date returns of a 7.3% decline and an 11.9% decline compare with a 1 year return of 2.4% and a 3 year gain of 63.5% that extends to 82.9% over 5 years. Recent coverage has focused on Raymond James Financial's role within the broader capital markets...